SFRP4 as an epigenetic biomarker of colorectal cancer risk
There is a lack of robust biomarkers of CRC risk. Epigenetic changes in the WNT-related SFRP4, a gene whose expression is down-regulated early in CRC development, may be a potential CRC risk biomarker. If SFRP4 promoter methylation proved to be a useful biomarker of CRC risk, it would have potential...
| Main Author: | |
|---|---|
| Published: |
University of Newcastle upon Tyne
2014
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.639772 |